Chuan Living Wang

US Patent:

20220348875, Nov 3, 2022

Filed:

Dec 17, 2021

Appl. No.:

17/645004

Inventors:

- Florham Park NJ, US
Qian Ye - Florham Park NJ, US
Tianjian Li - Belle Mead NJ, US
Chuan Wang - Montville NJ, US
Mini Bharathan - Berkeley Heights NJ, US
Uri Herzberg - Bridgewater NJ, US
Robert J. HARIRI - Bernardsville NJ, US

Assignee:

Celularity Inc. - Florham Park NJ

International Classification:

C12N 5/0783
A61K 35/17
C07K 14/735
A61K 45/06
A61P 35/00

Abstract:

Provided herein are genetically modified (GM) natural killer (NK) cells and methods of producing populations of GM NK cells. Further provided herein are methods of using the GM NK cells described herein, to, e.g., suppress the proliferation of tumor cells, or to inhibit pathogen infection, e.g., viral infection. In certain alternatives, GM NK cells provided herein lack expression of CBLB, NKG2A and/or TGFBR2 and/or function or show reduced expression and/or function of CBLB, NKG2A and/or TGFBR2. In certain alternatives, GM NK cells provided herein comprise modified CD16.

US Patent:

20220251614, Aug 11, 2022

Filed:

Apr 22, 2022

Appl. No.:

17/726926

Inventors:

- South San Francisco CA, US
Chuan Wang - South San Francisco CA, US
Jessica Leigh Ochoa - South San Francisco CA, US
Cliff Rutt - South San Francisco CA, US

International Classification:

C12P 13/02
C12N 1/18
C12N 15/81
C12N 15/52
C12P 13/22

Abstract:

Disclosed herein are recombinant host cells and methods capable of producing a tyramine containing hydroxycinnamic acid amide compounds, derivatives and extracts. Some embodiments provided include, for example, consumable products containing the tyramine containing hydroxycinnamic acid amide produced by the recombinant host cells. Some embodiments provided herein are methods for producing a tyramine containing hydroxycinnamic acid amide or hydroxycinnamic acid amide derivative.

US Patent:

20220216048, Jul 7, 2022

Filed:

Jan 6, 2021

Appl. No.:

17/142641

Inventors:

- Santa Clara CA, US
Deenesh Padhi - Sunnyvale CA, US
Xinhai Han - Santa Clara CA, US
Hang Yu - San Jose CA, US
Chuan Ying Wang - Sunnyvale CA, US

Assignee:

Applied Materials, Inc. - Santa Clara CA

International Classification:

H01L 21/02

Abstract:

Exemplary methods of forming semiconductor structures may include forming a silicon oxide layer from a silicon-containing precursor and an oxygen-containing precursor. The methods may include forming a silicon nitride layer from a silicon-containing precursor, a nitrogen-containing precursor, and an oxygen-containing precursor. The silicon nitride layer may be characterized by an oxygen concentration greater than or about 5 at. %. The methods may also include repeating the forming a silicon oxide layer and the forming a silicon nitride layer to produce a stack of alternating layers of silicon oxide and silicon nitride.

US Patent:

20210040607, Feb 11, 2021

Filed:

Aug 6, 2020

Appl. No.:

16/986632

Inventors:

- Santa Clara CA, US
Hang Yu - Santa Clara CA, US
Kesong Hu - Pleasanton CA, US
Kristopher Enslow - San Jose CA, US
Masaki Ogata - Santa Clara CA, US
Wenjiao Wang - Santa Clara CA, US
Chuan Ying Wang - Sunnyvale CA, US
Chuanxi Yang - Los Altos CA, US
Joshua Maher - Santa Clara CA, US
Phaik Lynn Leong - Singapore, SG
Qi En Teong - Singapore, SG
Alok Jain - Singapore, SG
Nagarajan Rajagopalan - Santa Clara CA, US
Deenesh Padhi - Sunnyvale CA, US

Assignee:

Applied Materials, Inc. - Santa Clara CA

International Classification:

C23C 16/34
H01L 27/11524
H01L 27/11551
H01L 27/1157
H01L 27/11578
C23C 16/40

Abstract:

Exemplary methods of forming semiconductor structures may include forming a silicon oxide layer from a silicon-containing precursor and an oxygen-containing precursor. The methods may include forming a silicon nitride layer from a silicon-containing precursor, a nitrogen-containing precursor, and an oxygen-containing precursor. The silicon nitride layer may be characterized by an oxygen concentration greater than or about 5 at. %. The methods may also include repeating the forming a silicon oxide layer and the forming a silicon nitride layer to produce a stack of alternating layers of silicon oxide and silicon nitride.

US Patent:

20200227258, Jul 16, 2020

Filed:

Oct 9, 2019

Appl. No.:

16/597466

Inventors:

- Santa Clara CA, US
Ganesh BALASUBRAMANIAN - Fremont CA, US
Arkajit ROY BARMAN - Singapore, SG
Hidehiro KOJIRI - Sunnyvale CA, US
Xinhai HAN - Santa Clara CA, US
Deenesh PADHI - Sunnyvale CA, US
Chuan Ying WANG - Sunnyvale CA, US
Yue CHEN - Sunnyvale CA, US
Daemian Raj BENJAMIN RAJ - Fremont CA, US
Nikhil Sudhindrarao JORAPUR - Sunnyvale CA, US
Vu Ngoc Tran NGUYEN - Santa Clara CA, US
Miguel S. FUNG - Sunnyvale CA, US
Jose Angelo OLAVE - Angeles, PH
Thian Choi LIM - Singapore, SG

International Classification:

H01L 21/02
H01L 21/67

Abstract:

A method of forming a film stack with reduced defects is provided and includes positioning a substrate on a substrate support within a processing chamber and sequentially depositing polysilicon layers and silicon oxide layers to produce the film stack on the substrate. The method also includes supplying a current of greater than 5 ampere (A) to a plasma profile modulator while generating a deposition plasma within the processing chamber, exposing the substrate to the deposition plasma while depositing the polysilicon layers and the silicon oxide layers, and maintaining the processing chamber at a pressure of greater than 2 Torr to about 100 Torr while depositing the polysilicon layers and the silicon oxide layers.

US Patent:

20180273903, Sep 27, 2018

Filed:

Dec 28, 2017

Appl. No.:

15/857516

Inventors:

- Warren NJ, US
Qian Ye - Martinsville NJ, US
Tianjian Li - Belle Mead NJ, US
Chuan Wang - Montville NJ, US
Mini Bharathan - Berkeley Height NJ, US
Uri Herzberg - Bridgewater NJ, US

Assignee:

Celularity, Inc. - Warren NJ

International Classification:

C12N 5/0783
A61K 35/17
A61P 35/00
A61K 45/06
C07K 14/735

Abstract:

Provided herein are genetically modified (GM) natural killer (NK) cells and methods of producing populations of GM NK cells. Further provided herein are methods of using the GM NK cells described herein, to, e.g., suppress the proliferation of tumor cells, or to inhibit pathogen infection, e.g., viral infection. In certain alternatives, GM NK cells provided herein lack expression of CBLB, NKG2A and/or TGFBR2 and/or function or show reduced expression and/or function of CBLB, NKG2A and/or TGFBR2. In certain alternatives, GM NK cells provided herein comprise modified CD16.

US Patent:

20170187677, Jun 29, 2017

Filed:

Mar 16, 2017

Appl. No.:

15/461144

Inventors:

- Santa Clara CA, US
Steven Whittle - Redwood City CA, US
Chuan Wang - Vienna VA, US

International Classification:

H04L 29/12
G06F 9/455
G06F 17/30
G06F 9/50

Abstract:

Provisioning an Internet Protocol address is disclosed. A request to provision an Internet Protocol address to a virtual resource is received. An Internet Protocol address is automatically determined to allocate to the virtual resource. The determined Internet Protocol address was selected from a group of Internet Protocol addresses potentially available to be assigned to the virtual resource of the received request.

US Patent:

20160315872, Oct 27, 2016

Filed:

Apr 27, 2016

Appl. No.:

15/140392

Inventors:

- Santa Clara CA, US
Steven Whittle - Redwood City CA, US
Chuan Wang - Vienna VA, US

International Classification:

H04L 12/911
G06F 9/455
H04L 29/12
H04L 12/931
H04L 29/08

Abstract:

Processing infrastructure metadata information about a virtual resource of a virtual cloud is disclosed. Infrastructure metadata information is collected. The collected metadata information is about a virtual resource of a virtual cloud. A storage of infrastructure metadata information is updated. The updating of the storage of infrastructure metadata information is performed using the collected information.